Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Opportunities and obstacles for deep learning in biology and medicine
309
Zitationen
36
Autoren
2017
Jahr
Abstract
Abstract Deep learning, which describes a class of machine learning algorithms, has recently showed impressive results across a variety of domains. Biology and medicine are data rich, but the data are complex and often ill-understood. Problems of this nature may be particularly well-suited to deep learning techniques. We examine applications of deep learning to a variety of biomedical problems—patient classification, fundamental biological processes, and treatment of patients—and discuss whether deep learning will transform these tasks or if the biomedical sphere poses unique challenges. We find that deep learning has yet to revolutionize or definitively resolve any of these problems, but promising advances have been made on the prior state of the art. Even when improvement over a previous baseline has been modest, we have seen signs that deep learning methods may speed or aid human investigation. More work is needed to address concerns related to interpretability and how to best model each problem. Furthermore, the limited amount of labeled data for training presents problems in some domains, as do legal and privacy constraints on work with sensitive health records. Nonetheless, we foresee deep learning powering changes at both bench and bedside with the potential to transform several areas of biology and medicine.
Ähnliche Arbeiten
"Why Should I Trust You?"
2016 · 14.610 Zit.
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
2005 · 10.527 Zit.
A Comprehensive Survey on Graph Neural Networks
2020 · 8.878 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.447 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.944 Zit.
Autoren
- Travers Ching
- Daniel Himmelstein
- Brett K. Beaulieu‐Jones
- Alexandr A. Kalinin
- T. Brian
- Gregory P. Way
- Enrico Ferrero
- Paul‐Michael Agapow
- Michael Zietz
- Michael M. Hoffman
- Wei Xie
- Gail Rosen
- Benjamin J. Lengerich
- Johnny Israeli
- Jack Lanchantin
- Stephen Woloszynek
- Anne E. Carpenter
- Avanti Shrikumar
- Jinbo Xu
- Evan M. Cofer
- Christopher A. Lavender
- Srinivas C. Turaga
- Amr M. Alexandari
- Zhiyong Lu
- David J. Harris
- David DeCaprio
- Yanjun Qi
- Anshul Kundaje
- Yifan Peng
- Laura K. Wiley
- Marwin Segler
- Simina M. Boca
- S. Joshua Swamidass
- Austin Huang
- Anthony Gitter
- Casey S. Greene
Institutionen
- University of Hawaiʻi at Mānoa(US)
- Translational Therapeutics (United States)(US)
- University of Pennsylvania(US)
- University of Michigan(US)
- Harvard University(US)
- GlaxoSmithKline (United Kingdom)(GB)
- Imperial College London(GB)
- Princess Margaret Cancer Centre(CA)
- Vanderbilt University(US)
- Drexel University(US)
- Carnegie Mellon University(US)
- Stanford University(US)
- University of Virginia(US)
- Broad Institute(US)
- Toyota Technological Institute at Chicago(US)
- Princeton University(US)
- Trinity University(US)
- National Institutes of Health(US)
- National Institute of Environmental Health Sciences(US)
- Howard Hughes Medical Institute(US)
- Janelia Research Campus(US)
- National Center for Biotechnology Information(US)
- University of Florida(US)
- University of Colorado Denver(US)
- University of Münster(DE)
- Georgetown University(US)
- Georgetown University Medical Center(US)
- Washington University in St. Louis(US)
- Brown University(US)
- University of Wisconsin–Madison(US)
- Morgridge Institute for Research(US)